Wells Fargo lowered the firm’s price target on HCA Healthcare to $254 from $267 and keeps an Equal Weight rating on the shares. The firm says estimates for 2024 needed to come down as the headwind from Velasco and professional fees came into greater focus. Headwinds are increasingly clear. Wells is focused on tailwinds and how HCA plans to respond. Details could start to emerge at Investor Day, the firm adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on HCA:
- HCA Healthcare price target lowered to $276 from $298 at Leerink
- HCA Healthcare price target lowered to $300 from $340 at Truist
- HCA Healthcare price target lowered to $280 from $300 at Stephens
- HCA Healthcare price target lowered to $284 from $315 at RBC Capital
- HCA Healthcare price target lowered to $265 from $326 at TD Cowen
